EMA Authorizes Hemophilia B Gene Therapy
In its May 2024 meeting, the European Medicines Agency (EMA) gave the go-ahead for Durveqtix to treat severe and moderately ...
Read moreDetailsIn its May 2024 meeting, the European Medicines Agency (EMA) gave the go-ahead for Durveqtix to treat severe and moderately ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info